{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:27:40Z","timestamp":1791307660070,"version":"4.3.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.pharmthera.2005.03.006","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T13:39:29Z","timestamp":1117633169000},"page":"329-342","source":"Crossref","is-referenced-by-count":46,"title":["Ross River virus: Molecular and cellular aspects of disease pathogenesis"],"prefix":"10.1016","volume":"107","author":[{"given":"Nestor E.","family":"Rulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hueston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tupanceska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Wilmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Lidbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendran","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4269\/ajtmh.1981.30.1053","article-title":"An epidemic of Ross River virus infection in Fiji, 1979","volume":"30","author":"Aaskov","year":"1981","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.iy.02.040184.001435","article-title":"The cell biology of macrophage activation","volume":"2","author":"Adams","year":"1984","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib3","first-page":"101","article-title":"Ross River virus infections in the north-west outskirts of the Sydney basin","volume":"22","author":"Amin","year":"1998","journal-title":"\"\"Commun Dis Intell"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1099\/0022-1317-77-2-281","article-title":"Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis","volume":"77","author":"Amor","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/viro.2000.0458","article-title":"Differencial regulation of Bcl-2 and Bax expression in cells infected with virulent and nonvirulent strains of Sindbis virus","volume":"276","author":"Appel","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib6","first-page":"5","article-title":"Arboviral diseases of horses and possums","volume":"7","author":"Azoulas","year":"1997","journal-title":"Arbovirus Res Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib7","first-page":"56","article-title":"Ross River virus disease of horses","volume":"16","author":"Azoulas","year":"1998","journal-title":"Aust Equine Vet"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5694\/j.1326-5377.2002.tb04836.x","article-title":"Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months","volume":"177","author":"Bossingham","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jmedent\/26.2.100","article-title":"Isolation of Murray Valley encephalitis and Ross River viruses from Aedes normanensis (Diptera: Culcidae) in Western Australia","volume":"26","author":"Broom","year":"1989","journal-title":"J Med Entomol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0092-8674(95)90516-2","article-title":"Nucleocapsid and glycoprotein organization in an enveloped virus","volume":"80","author":"Cheng","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1445-5994.1975.tb03056.x","article-title":"Epidemic polyarthritis: a cytological, virological and immunochemical study","volume":"5","author":"Clarris","year":"1975","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0928-0197(94)00043-3","article-title":"Acute symptoms and sequelae of Ross River virus disease infection in South-Western Australia: a follow-up study","volume":"3","author":"Condon","year":"1995","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2567.1997.00310.x","article-title":"Human cytomegalovirus infection up-regulates interlukin-8 gene expression and stimulates neutrophil transendothelial migration","volume":"92","author":"Craigen","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib15","series-title":"Encyclopedia of Virology","article-title":"Ross River virus and Barmah Forest virus (Togaviridae)","author":"Dalgarno","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0042-6822(76)90329-9","article-title":"Persistent noncytolityc togavirus infection of primary mouse cells","volume":"72","author":"Eaton","year":"1976","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0042-6822(88)90292-9","article-title":"Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus","volume":"163","author":"Faragher","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4269\/ajtmh.1984.33.1228","article-title":"Characterization of Ross River viruses isolated from patients with polyarthritis in New Caledonia and Wallis and Futuna Islands","volume":"33","author":"Fauran","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5694\/j.1326-5377.1998.tb116019.x","article-title":"A comparison of the disease caused by Ross River virus and Barmah Forest virus","volume":"169","author":"Flexman","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1445-5994.1984.tb03629.x","article-title":"Mononuclear cell types in chronic synovial effusions of Ross River virus disease","volume":"14","author":"Fraser","year":"1984","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0307-742X(21)00556-7","article-title":"Epidemic polyarthritis and Ross River virus disease","volume":"12","author":"Fraser","year":"1986","journal-title":"Clin Rheum Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib24","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.4049\/jimmunol.161.9.4803","article-title":"Autocrine\/paracrine IFN-\u03b1\u03b2 mediates the lipopolysaccharide-induced activation of transcription factor Stat1\u03b1 in mouse macrophages: pivotal role of Stat1\u03b1 in induction of the inducible nitric oxide synthase gene","volume":"161","author":"Gao","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4269\/ajtmh.1973.22.551","article-title":"Annually recurrent epidemic polyarthritis and Ross River virus activity in a coastal area of New South Wales: II. Mosquitoes, viruses and wildlife","volume":"22","author":"Gard","year":"1973","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib26","doi-asserted-by":"crossref","unstructured":"Gatton, M., Kelly-Hope, L., Kay, B., & Ryan, P. (in press). Spatial\u2013temporal analysis of Ross River virus disease patterns in Queensland, Australia. Am J Trop Med Hyg.","DOI":"10.4269\/ajtmh.2004.71.629"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/keg459","article-title":"Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy","volume":"43","author":"Gong","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G","article-title":"Elevated plasma interlukin-10 levels in acute dengue correlate with disease severity","volume":"59","author":"Green","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1997.8617","article-title":"Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan Equine Encephalitis virus","volume":"233","author":"Grieder","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib33","unstructured":"Harley, D. O. (2000). Ross River virus: ecology, natural history of disease and epidemiology in tropical Queensland. PhD thesis, University of Queensland, Australia."},{"key":"10.1016\/j.pharmthera.2005.03.006_bib32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/CMR.14.4.909-932.2001","article-title":"Ross River virus transmission, infection, and disease a cross-disciplinary review","volume":"14","author":"Harley","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5694\/j.1326-5377.2002.tb04836.x","article-title":"Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months","volume":"177","author":"Harley","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib35","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1128\/JVI.75.14.6303-6309.2001","article-title":"An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety","volume":"75","author":"Heil","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib37","doi-asserted-by":"crossref","first-page":"47950","DOI":"10.1074\/jbc.M106639200","article-title":"Lipopolysaccharide-induced expression of interferon-\u03b3 mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages","volume":"276","author":"Jacobs","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib38","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","article-title":"Monocyte chemoattractant protein-1 regulates molecule expression and cytokine production in human monocytes","volume":"148","author":"Jiang","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib39","series-title":"Fields Virology","article-title":"Alphaviruses","author":"Johnston","year":"1996"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib40","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1099\/0022-1317-68-12-3165","article-title":"Prolonged infection of human synovial cells with Ross River virus","volume":"68","author":"Journeaux","year":"1987","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0952-7915(96)80033-1","article-title":"Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses","volume":"8","author":"Kagi","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine Induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib43","series-title":"International Catalogue of Arboviruses","author":"Karabatsos","year":"1985"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib44","first-page":"421","article-title":"Alphavirus infection in mosquitoes at the Ross River reservoir, North Queensland, 1990\u20131993","volume":"12","author":"Kay","year":"1996","journal-title":"J Am Mosq Control Assoc"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1603\/0022-2585-41.2.133","article-title":"Ross River virus disease in Australia, 1886\u20131998, with analysis of risk factors associated with outbreaks","volume":"41","author":"Kelly-Hope","year":"2004","journal-title":"J Med Entomol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue haemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am Soc Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib48","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1128\/JVI.71.10.7488-7497.1997","article-title":"Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages","volume":"71","author":"Lechner","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib49","first-page":"1053","article-title":"Expression of cytokine mRNA in lentivirus-induced arthritis","volume":"151","author":"Lechner","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm813","article-title":"Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways","volume":"9","author":"Leitner","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/08830180490265529","article-title":"Alphaviruses and apoptosis","volume":"23","author":"Li","year":"2004","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib53","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-74-10-2111","article-title":"CD8+ cytotoxic T lymphocytes against antigenic variants of caprine arthritis\u2013encephalitis virus","volume":"74","author":"Lichtensteiger","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib54","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1128\/JVI.74.18.8376-8381.2000","article-title":"Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection","volume":"74","author":"Lidbury","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib55","series-title":"Chemokines in Viral Infections","article-title":"A role for chemokine activity in alphavirus pathogenesis: evidence from the analysis of polyarthritis and myalgia post Ross River virus infection","author":"Lidbury","year":"2004"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/315164","article-title":"Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice","volume":"181","author":"Lidbury","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib58","first-page":"72","article-title":"The epidemiology of outbreaks of Ross River virus infection in Western Australia in 1991\u20131992","volume":"6","author":"Lindsay","year":"1992","journal-title":"Arbovirus Res Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib57","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/JVI.67.6.3576-3585.1993","article-title":"Genetic heterogeneity among isolates of Ross River virus from different geographical regions","volume":"67","author":"Lindsay","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3201\/eid0202.960206","article-title":"An outbreak of Ross River virus disease in Southwestern Australia","volume":"2","author":"Lindsay","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1099\/0022-1317-77-3-407","article-title":"Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis","volume":"77","author":"Linn","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib61","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JVI.72.6.5146-5153.1998","article-title":"Alphaviurs-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from capsid protein and can eliminate virus from persistently infected macrophages","volume":"72","author":"Linn","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/JVI.69.1.469-475.1995","article-title":"The 6 kilodalton membrane protein of Semliki Forest virus is involved in the budding process","volume":"69","author":"Loewy","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01321074","article-title":"Arboviruses causing human disease in the Australasian zoogeographic region","volume":"136","author":"Mackenzie","year":"1994","journal-title":"Arch Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib67","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.202415999","article-title":"Suppression of lipolysaccharide-induced antiviral transcription factor (STAT-1 and NF-\u03baB) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus","volume":"99","author":"Mahalingam","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bies.1061","article-title":"Antiviral potential of chemokines","volume":"23","author":"Mahalingam","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0966-842X(03)00157-4","article-title":"Chemokines and viruses: friends or foes","volume":"11","author":"Mahalingam","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib68","first-page":"6","article-title":"COX-2 Inhibitors: a CLASS Act or Just VIGORously Promoted","volume":"23","author":"Malhotra","year":"2004","journal-title":"Med Gen Med"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib69","first-page":"31","article-title":"Ross River virus and epidemic polyarthritis","volume":"2","author":"Marshall","year":"1984","journal-title":"Curr Top Vector Res"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000025023","article-title":"An arthrogenic alphavirus induces monocyte chemoatractant protein-1 and interlukin-8","volume":"43","author":"Mateo","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib71","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","article-title":"Macrophage inflammatory protein-1","volume":"36","author":"Maurer","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"Suppl 28","key":"10.1016\/j.pharmthera.2005.03.006_bib72","first-page":"S130","article-title":"TNF involvement and anti-TNF therapy of reactive and unclassified arthritis","volume":"6","author":"Meador","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib73","doi-asserted-by":"crossref","first-page":"46923","DOI":"10.1074\/jbc.M207847200","article-title":"Alphavirus 6K proteins form ion channels","volume":"277","author":"Melton","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/infdis\/127.2.121","article-title":"Pathogenesis of Ross River virus infection in mice: I. Ependymal infection, cortical thinning, and Hydrocephalus","volume":"127","author":"Mims","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib75","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1099\/0022-1317-71-12-2909","article-title":"Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies","volume":"71","author":"Morens","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/infdis\/127.2.129","article-title":"Pathogenesis of Ross River virus infection in mice: II. Muscle, heart, and brown fat lesions","volume":"127","author":"Murphy","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2002.tb04837.x","article-title":"Natural history of Ross River virus-induced epidemic polyarthritis","volume":"177","author":"Mylonas","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib78","unstructured":"Mylonas, A. D., Harley, D., Purdie, D. M., Pandeya, N., Vecchio, P. C., Farmer, J. F., & Suhrbier, A. (in press). Steroid therapy in an alphaviral arthritis. J Clin Rheum."},{"key":"10.1016\/j.pharmthera.2005.03.006_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JVI.67.1.75-81.1993","article-title":"Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes","volume":"67","author":"Niewiesk","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jmv.1890360312","article-title":"Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinnin monoclonal antibody","volume":"36","author":"Ochiai","year":"1992","journal-title":"J Med Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0889-857X(02)00097-2","article-title":"Hepatitis C virus and arthritis","volume":"29","author":"Olivieri","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib82","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1471-4892(03)00080-8","article-title":"Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases","volume":"3","author":"O'Neill","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2004.01976.x","article-title":"Signal transduction by lipopolysaccharide receptor, Toll-like receptor-4","volume":"113","author":"Palsson-McDermott","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/282509a0","article-title":"Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines","volume":"282","author":"Peiris","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/289189a0","article-title":"Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages","volume":"289","author":"Peiris","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib86","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/374604","article-title":"Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model","volume":"187","author":"Ponnuraj","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0966-842X(00)01919-3","article-title":"Hijacking and exploitation of IL-10 by intracellular pathogens","volume":"9","author":"Redpath","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jmedent\/34.2.156","article-title":"Ross River virus in mosquitoes (Diptera: Culicidae) during the 1994 epidemic around Brisbane, Australia","volume":"34","author":"Ritchie","year":"1997","journal-title":"J Med Entomol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib91","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4049\/jimmunol.162.3.1624","article-title":"The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB\/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells","volume":"162","author":"Rowell","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-8574(98)00057-3","article-title":"Constructed wetlands and mosquitoes: health hazards and management options\u2014an Australian perspective","volume":"12","author":"Russell","year":"1998","journal-title":"Ecol Eng"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.ento.47.091201.145100","article-title":"Ross River virus: ecology and distribution","volume":"47","author":"Russell","year":"2000","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib94","first-page":"76","article-title":"The surveillance of arbovirus activity in NSW 1989\u20131992","volume":"6","author":"Russell","year":"1992","journal-title":"Arbovirus Res Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib97","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4269\/ajtmh.1997.57.476","article-title":"Investigation of gray-headed flying foxes, Pteropus poliocephalus (Megachiroptera: Pteropodidae) and mosquitoes in the ecology of Ross River virus in Australia","volume":"57","author":"Ryan","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib95","first-page":"341","article-title":"Heterogeneity of risk of Ross River virus disease: implications for residential development and vector control programs","volume":"8","author":"Ryan","year":"2001","journal-title":"Arbovirus Res Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5694\/j.1326-5377.2003.tb05120.x","article-title":"Itching bites may limit Ross River virus infection","volume":"178","author":"Ryan","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib98","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1128\/JVI.75.16.7778-7784.2001","article-title":"Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans","volume":"75","author":"Sanz","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib99","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.31.6.656","article-title":"Experimental viral polymyositis: age dependency and immune responses to Ross River virus infection in mice","volume":"31","author":"Seay","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5694\/j.1326-5377.1996.tb124989.x","article-title":"Changing epidemiology of Ross River virus disease in South Australia","volume":"165","author":"Selden","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(02)00203-6","article-title":"Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control","volume":"57","author":"Sidwell","year":"2003","journal-title":"Antivir Res"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib102","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E","article-title":"Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection","volume":"43","author":"Soden","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib103","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses, gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1471-4906(03)00065-6","article-title":"Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection","volume":"24","author":"Suhrbier","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.bor.0000130537.76808.26","article-title":"Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses","volume":"16","author":"Suhrbier","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib106","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1128\/JVI.77.13.7539-7544.2003","article-title":"Antibody-dependent enhancement of Ebola virus infection","volume":"77","author":"Takada","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib107","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1128\/JVI.73.7.5309-5319.1999","article-title":"In vitro assembly of alphaviruses cores by using nucleocaspid protein expressed in Escherichia coli","volume":"73","author":"Tellinghuisen","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib108","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.165.1.286","article-title":"IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3","volume":"165","author":"Tone","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1444-0903.2004.00520.x","article-title":"Ross River virus disease in Australia: epidemiology, socioecology and public health response","volume":"34","author":"Tong","year":"2004","journal-title":"Int Med J"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4269\/ajtmh.2001.65.171","article-title":"Geographical variation of notified Ross River virus infections in Queensland, 1985\u201396","volume":"65","author":"Tong","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib111","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V99.4.1465","article-title":"Blockade of B7\/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses","volume":"99","author":"Tzachanis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib112","first-page":"367","article-title":"Late onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function","volume":"63","author":"Verder","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib113","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0042-6822(86)90044-9","article-title":"Ross River virus mutant with a deletion in the E2 gene: properties of the virion, virus-specific macromolecule synthesis, and attenuation of virulence for mice","volume":"151","author":"Vrati","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib114","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0042-6822(88)90474-6","article-title":"Location of a major antigenic site involved in Ross River virus neutralization","volume":"162","author":"Vrati","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/viro.2002.1587","article-title":"Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection","volume":"301","author":"Way","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1467-842X.1996.tb01343.x","article-title":"Ross River virus infection on the North Coast of New South Wales","volume":"20","author":"Westley-Wise","year":"1996","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib117","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0960-9822(93)90007-B","article-title":"Integrins as virus receptors","volume":"3","author":"White","year":"1993","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib119","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00002281-199907000-00009","article-title":"Viral arthritis","volume":"11","author":"Ytterberg","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib120","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.172.9.5656","article-title":"Arthritogenic properties of double-stranded (viral) RNA","volume":"172","author":"Zare","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2005.03.006_bib121","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ijc.2910410324","article-title":"Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes","volume":"41","author":"Zielgler-Heitbrock","year":"1988","journal-title":"Int J Cancer"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T11:32:25Z","timestamp":1706268745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0163725805000665"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.03.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}